Tech Company Financing Transactions

Neurotech Pharmaceuticals Funding Round

Burrill & Company, Apax Partners and Atlas Venture invested in a $35 million Series B funding round for Neurotech Pharmaceuticals. The financing was announced on 11/16/2006.

Transaction Overview

Company Name
Neurotech Pharmaceuticals
Announced On
11/16/2006
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors

Burrill & Company (Lead Investor) (Bryant Fong)

Apax Partners (Laurent Ganem)

Atlas Venture

Merlin BioMed Group

SV Health Investors (Lutz Giebel)

Versant Ventures (William Link)

Proceeds Purpose
This financing will enable Neurotech to obtain primary efficacy results for three important Phase II studies that the company is carrying out for its lead product, NT-501, involving its proprietary Encapsulated Cell Technology (ECT). These studies address atrophic macular degeneration (dry AMD), and early and late stage retinitis pigmentosa.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Highland Corporate Dr. Building 1 101
Lincoln, RI 02864
USA
Phone
(401) 333-3880
Website
www.neurotechusa.com
Email Address
[email protected]
Overview
Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology.
Profile
Neurotech Pharmaceuticals LinkedIn Company Profile
Social Media
Neurotech Pharmaceuticals Company Twitter Account
Company News
Neurotech Pharmaceuticals News
Facebook
Neurotech Pharmaceuticals on Facebook
YouTube
Neurotech Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Small
  Richard Small LinkedIn Profile  Richard Small Twitter Account  Richard Small News  Richard Small on Facebook
VP - Bus. Development
Konrad Kauper
  Konrad Kauper LinkedIn Profile  Konrad Kauper Twitter Account  Konrad Kauper News  Konrad Kauper on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/16/2006: W5 Networks venture capital transaction
Next: 11/16/2006: Health Hero Network venture capital transaction

 

Share this article

 

News on VC Transactions

We document tech company VC transactions. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.